Resources Contact Us Home
Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof

Image Number 14 for United States Patent #8106164.

The invention pertains to the development of antibodies that specifically bind amyloid beta protein (Abeta) in its protofibril conformation. The invention also comprises methods of using anti-Abeta protofibril antibodies to diagnose or treat Alzheimer's disease, Down's syndrome Lewybody dementia, vascular dementia, and other neurodegenerative disorders. Furthermore, the invention pertains to the use of anti-Abeta protofibril antibodies to screen and identify substances that will modulate protofibril activity or formation in vitro or in vivo. The invention also pertains to methods for synthesising pure Abeta protofibril antigens as well as to a method for stabilising Abeta protofibrils antigens as well as to a method for stabilising Abeta protofibrils.

  Recently Added Patents
Bit error mitigation
Compositions of quaternary ammonium compounds containing bioavailability enhancers
Starch networks as absorbent or superabsorbent materials and their preparation by extrusion
Interconnect, bus system with interconnect and bus system operating method
Scoring records for sorting by user-specific weights based on relative importance
Laser processing method and apparatus
SONOS stack with split nitride memory layer
  Randomly Featured Patents
Method of manufacturing a combination type thin film magnetic head
Method of curing a fuser member overcoat at low temperatures
Wireless train proximity alert system
Non-destructive evaluation of geological material structures
Right-to-left scanning system for copying documents or bound books
Antenna arrangement for a wireless communication device
Sealed container
Method for improving chemometric estimations of properties of materials
Workload placement based on thermal considerations